Delivery Order SPE2DB20D2014-SPE2DB25FC82J
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $18,837.70 delivery order on August 19, 2025, for the supply of Remicade 100 mg vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $38,665.68 by the Defense Logistics Agency on August 27, 2025, for the supply of Remicade 100 mg vials. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,603.96 on July 29, 2025, for the supply of Remicade 100 mg vials, with a completion date of July 30, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $50,458.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 21, 2025. This is a non-set-aside competitive award issued on August 20, 2025, with performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $17,733.06 from the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Remicade 100 mg vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $5,012.20 to supply 100 mg vials of Remicade, a biologic immunosuppressant medication used to treat autoimmune conditions. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $23,484.87 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 12, 2025. This firm fixed price contract, awarded on August 11, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,774.78 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling through December 2026. The delivery order was executed on August 4, 2025, with an ultimate completion date of August 5,...
- The Defense Logistics Agency awarded a delivery order valued at $2,366.24 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $10,024.40 firm fixed price delivery order is for the supply of Remicade 100 mg vials, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC82JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Remicade 100 mg vials, a TNF-alpha inhibitor immunosuppressant used primarily for rheumatologic and gastrointestinal conditions. This firm fixed-price contract, valued at $12,877.18, represents a competitively awarded non-set-aside procurement with performance scheduled for completion by August 26, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and active through December 2026, which serves as the comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, has demonstrated sustained capability in fulfilling Defense Logistics Agency medical procurement requirements through open competition. The company's extensive federal contract portfolio reflects its role as a key supplier for military and veteran healthcare systems, consistently delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This particular delivery order continues the vendor's ongoing support of the Defense Health Agency and broader Department of Defense medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 8/25/25 |